BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yang HJ, Jiang JH, Yang YT, Yang XD, Guo Z, Qi YP, Zeng FH, Zhang KL, Chen NZ, Xiang BD, Li LQ. Cyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survival. World J Gastroenterol 2016; 22(39): 8798-8805 [PMID: 27818595 DOI: 10.3748/wjg.v22.i39.8798]
URL: https://www.wjgnet.com/1007-9327/full/v22/i39/8798.htm
Number Citing Articles
1
Chongming Zheng, Fei Lu, Bo Chen, Jinhuan Yang, Haitao Yu, Daojie Wang, Haonan Xie, Kaiwen Chen, Yitong Xie, Jiacheng Li, Zhiyuan Bo, Yi Wang, Gang Chen, Tuo Deng. Gut microbiome as a biomarker for predicting early recurrence of HBV‐related hepatocellular carcinomaCancer Science 2023; 114(12): 4717 doi: 10.1111/cas.15983
2
Mudan Ren, Eileen McGowan, Yarui Li, Xiaofeng Zhu, Xinlan Lu, Zhanfang Zhu, Yiguang Lin, Shuixiang He. Saikosaponin-d Suppresses COX2 Through p-STAT3/C/EBPβ Signaling Pathway in Liver Cancer: A Novel Mechanism of ActionFrontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00623
3
Umar Mushtaq. EP1 receptor: Devil in emperors coatJournal of Cellular Biochemistry 2023; 124(8): 1105 doi: 10.1002/jcb.30436
4
Yong-Jiang Xu, Zhaojun Zheng, Chen Cao, Jinwei Li, Yuanfa Liu. Bioanalytical insights into the association between eicosanoids and pathogenesis of hepatocellular carcinomaCancer and Metastasis Reviews 2018; 37(2-3): 269 doi: 10.1007/s10555-018-9747-8
5
Chao Chen, Jun Guan, Xinyu Gu, Qingfei Chu, Haihong Zhu. Prostaglandin E2 and Receptors: Insight Into Tumorigenesis, Tumor Progression, and Treatment of Hepatocellular CarcinomaFrontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.834859
6
Yu-Ting Yang, Jing-Hang Jiang, Hao-Jie Yang, Zhi-jun Wu, Ze-Min Xiao, Bang-De Xiang. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resectionScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-20199-2
7
Liang Sang, Xue-Mei Wang, Dong-Yang Xu, Wen-Jing Zhao. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinomaWorld Journal of Gastroenterology 2018; 24(24): 2605-2616 doi: 10.3748/wjg.v24.i24.2605
8
Qin Wang, Donghui Lu, Lulu Fan, Yuhuan Li, Yu Liu, Hanqing Yu, Hua Wang, Jiatao Liu, Guoping Sun. COX-2 induces apoptosis-resistance in hepatocellular carcinoma cells via the HIF-1α/PKM2 pathwayInternational Journal of Molecular Medicine 2018;  doi: 10.3892/ijmm.2018.3936
9
Hao-Jie Yang, Jing-Hang Jiang, Qing-An Liu, Cheng-Mao Zhou, Yang-feng Du, Tao Wu, Neng-Zhi Chen, Bang-De Xiang. Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resectionTumor Biology 2017; 39(6): 101042831770737 doi: 10.1177/1010428317707375
10
María de Luján Alvarez, Florencia Lorenzetti. Role of eicosanoids in liver repair, regeneration and cancerBiochemical Pharmacology 2021; 192: 114732 doi: 10.1016/j.bcp.2021.114732
11
Bi‑Yun Zheng, Wen‑Yu Gao, Xiao‑Yun Huang, Li‑Ying Lin, Xue‑Fen Fang, Zhi‑Xin Chen, Xiao‑Zhong Wang. HBx promotes the proliferative ability of HL‑7702 cells via the COX‑2/Wnt/β‑catenin pathwayMolecular Medicine Reports 2018;  doi: 10.3892/mmr.2018.8906